Prognostic Impacts of CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis-Reference-Cited by-同舟云学术

Prognostic Impacts of CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis

Published:2023-04-10 Issue:4 Volume:5 Page:123-132
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Ukaji Tomoaki¹,Ishikawa Tetsuya¹,Nakamura Hidehiko¹,Mizutani Yukiko¹,Yamada Kouta¹,Shimura Masatoshi¹,Kondo Yuki¹,Tamura Yohei¹,Koshikawa Yuri¹,Hisauchi Itaru¹,Nakahara Shiro¹,Itabashi Yuji¹,Kobayashi Sayuki¹,Taguchi Isao¹

Affiliation:

1. Department of Cardiology, Dokkyo Medical University, Saitama Medical Center

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/5/4/5_CR-22-0120/_pdf

Reference26 articles.

1. 1. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020; 84: 831–865.

2. 2. Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel MA, et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the “all-comers” LEADERS trial. Circ Cardiovasc Interv 2011; 4: 47–56.

3. 3. Wykrzykowska J, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the SYNTAX score (SX) for risk assessment in the “all-comers” population of the randomized multicenter LEADERS trial. J Am Coll Cardiol 2010; 56: 272–277.

4. 4. Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: CREDO-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc 2018; 7: e008708.

5. 5. Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. A consensus document from the Academic Research Consortium for High Bleeding Risk. Circulation 2019; 140: 240–261.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Stroke Risk Scoring Systems in Patients with Non-Valvular Atrial Fibrillation;Advances in Clinical Medicine;2023